Leo discusses the intricate relationship between antibodies and immune networks, highlighting how they can both control and aggravate inflammation. He points out the significance of antiphospholipid antibodies in blood clotting and notes the presence of autoantibodies related to COVID-19, particularly those affecting ACE2 function. Understanding these dynamics is crucial, as the impact of autoantibodies largely depends on the level of cell damage and inflammation present.
